Clinical Trials
Closed
Phase
SWOG Clinical Trial Number
SWOG-8518
Study of Combined Modality Treatment For Inoperable Squamous Cell Carcinoma of the Esophagus (Stage III By Moss Classification)
Activated
10-15-1986
Closed
06-01-1988
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-8520
Cis-Diamminedichloroplatinum (II), Methotrexate and Bleomycin in the Treatment of Advanced Epidermoid Carcinoma of the Penis
Research Committee(s)
Genitourinary Cancer
Activated
09-01-1986
Closed
09-01-1994
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8606
Treatment of Small Cell Lung Cancer Using an Intensive, Multidrug, Weekly Treatment Program of Short Duration
Activated
08-29-1986
Closed
08-01-1987
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8565
Evaluation of Menogaril (NSC-269148) in Colorectal Carcinoma
Activated
08-01-1986
Closed
03-01-1988
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8569
Therapy of Metastatic Malignant Melanoma with Recombinant Human Interleukin-2.
Activated
08-01-1986
Closed
10-01-1988
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8526
The Clinical Antitumor Activity of Recombinant Beta Interferon in Diffuse Mesothelioma
Activated
08-01-1986
Closed
07-15-1988
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8324
Evaluation of Fludarabine Phosphate in Malignant Melanoma
Activated
06-15-1986
Closed
08-15-1988
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8505
Evaluation of Echinomycin in Advanced Soft Tissue Sarcomas
Activated
06-15-1986
Closed
02-15-1988
Closed
Phase
Accrual
64%
Published
SWOG Clinical Trial Number
SWOG-8572
Pilot Study of Continuous Low-Dose 5-Fluorouracil Infusion and Radiation Therapy as Adjuvant Treatment for Duke's-C Colon and Rectal Cancer
Activated
05-09-1986
Closed
06-15-1991
Closed
Phase
Accrual
98%
Published
SWOG Clinical Trial Number
SWOG-8501 (INT-0051)
Intraperitoneal Cis-Platinum/Intravenous Cyclophosphamide Versus Intravenous Cis-Platinum/ Intravenous Cyclophosphamide in Patients with Non-Measurable (Optimal) Disease Stage III Ovarian Cancer
Research Committee(s)
Gynecologic Cancer
Activated
05-09-1986
Closed
07-15-1992
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8571
Induction Chemotherapy With High-Dose Cyclophosphamide for Poor Prognosis, Disseminated Breast Cancer, with Radiation Therapy in Complete Responders
Activated
04-15-1986
Closed
01-01-1988
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-8516 (INT-0067)
A Phase III Comparison of CHOP Versus m-BACOD Versus ProMACE-CytaBOM Versus MACOP-B in Patients with Intermediate or High-Grade Non-Hodgkin's Lymphoma
Research Committee(s)
Lymphoma
Activated
04-04-1986
Closed
06-15-1991
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8573
Treatment of Limited Small Cell Lung Cancer with Concurrent Chemotherapy, Radiotherapy, and Intensification with High-Dose Cyclophosphamide
Activated
03-21-1986
Closed
05-01-1988
Closed
Phase
Accrual
85%
Published
SWOG Clinical Trial Number
SWOG-8568
Combined Modality Therapy for Advanced Stage III Breast Cancer or Localized Stage IV (T3B, Any N, T3aN2-3, or Any T4)
Activated
03-04-1986
Closed
11-15-1990
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8522
Treatment of Acute Non-Lymphocytic Leukemia Patients Over 50 Years
Activated
02-17-1986
Closed
11-01-1987
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8517
Phase II Study of Platinum and Mitoxantrone in the Treatment of Metastatic Adenocarcinoma of the Prostate
Activated
02-10-1986
Closed
08-01-1987
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8513
Evaluation of Menogaril (NSC-269148) in Pancreatic Adenocarcinoma
Activated
01-03-1986
Closed
02-15-1987
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8567
Evaluation of Menogaril (NSC-269148) in Non-Small Cell Lung Carcinoma
Activated
01-03-1986
Closed
08-01-1987
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8562
High-Dose Cisplatin in Hypertonic Saline for the Treament of Metastatic or Recurrent Malignant Melanoma
Activated
01-03-1986
Closed
02-15-1990
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8519
Phase II Evaluation of Methyl-Glyoxal Bis- Guanylhydrazone (MGBG) in Patients With Advanced Bladder Cancer
Activated
01-01-1986
Closed
05-15-1989